Clinical Trials Sponsored by Concord Hospital

Total 99962 results

Concord Repatriation General Hospital

Completed

Effect of Warmed Humidified CO2 on Peritoneum During Laparotomy

Peritoneal Inflammation | Peritoneum; Injury

Australia
Concord Repatriation General Hospital

Recruiting

HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound Visualisation

HCC | Hepatocellular Carcinoma

Australia, New Zealand
Vaginal Biome Science
Concord Hospital

Completed

Clinical Trial to Survey Results of Flourish Vaginal Care System for Recurrent Bacterial Vaginosis

Vaginal Flora Imbalance | Bacterial Vaginosis

United States
Concord Hospital
Franklin Pierce University

Withdrawn

Dry Needling for Patients With Back Pain

Back Pain

United States
Guangzhou Concord Cancer Center

Recruiting

Effects of Music Therapy on Psychological States Among Cancer Patients Undergoing MRI Scans and A Relevant Mediator

Psycho-Oncology

China
Concordia Hospital Rome

Completed

Hymovis® Intra-articular Injections vs Corticosteroids Intra-articular Injections in Patients Affected by Glenohumeral Osteoarthritis:

Glenohumeral Osteoarthritis

Italy
Franklin Pierce University
Newcastle University; Concord Hospital

Completed

Dry Needling for Patients With Neck Pain

Neck Pain

United States
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Concert Pharmaceuticals

Completed

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers

Healthy

United States
Concert Pharmaceuticals

Completed

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

Healthy Volunteers

Australia
Concert Pharmaceuticals

Completed

Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease

Stage 3 Chronic Kidney Disease

United States
Michael Dunbar
Maisonneuve-Rosemont Hospital; Concord Hospital

Completed

DePuy Attune Total Knee Arthroplasty RSA Study

Osteoarthritis

Canada
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Completed

Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543

Hepatic Impairment

United States
Concert Pharmaceuticals

Completed

Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects

Healthy Volunteers

United States
Concert Pharmaceuticals

Completed

Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers

Healthy

United States
Concert Pharmaceuticals

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CTP-543 in Healthy Subjects

Healthy

Australia
Concert Pharmaceuticals

Completed

Food Effect Study of CTP-656 in Healthy Male Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects

Healthy

Australia
Concert Pharmaceuticals

Completed

A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

A Phase 1, Single Dose Study of JZP-386 to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Narcolepsy, Excessive Daytime Sleepiness

United Kingdom
Concert Pharmaceuticals

Completed

Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz

Healthy Volunteers
Concert Pharmaceuticals

Enrolling by invitation

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Active, not recruiting

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

Spain, Germany, Poland, France, Hungary
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543

Renal Impairment

United States
Concert Pharmaceuticals

Completed

Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

Health Volunteers

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers

Healthy Volunteers

United States
Concert Pharmaceuticals

Completed

Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects

Healthy Volunteers

United States
Concert Pharmaceuticals

Completed

Food Effect Study of CTP-543 in Healthy Volunteers

Healthy

United States
Concert Pharmaceuticals

Completed

Open-Label Crossover Study Comparing CTP-543 to Jakafi®

Healthy

United States
Concert Pharmaceuticals

Completed

Healthy Volunteer Solid Oral Dose and Multiple Ascending Dose Evaluation of CTP-656

Healthy

Australia
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
Concert Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499

Diabetic Nephropathy

United States
Concordia University Wisconsin

Recruiting

Molecular Signature of Inactivity Induced Exercise Responsiveness

Metabolic Diseases | Aerobic Exercise

United States
Concordia University, Montreal

Recruiting

Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Muscle Atrophy | Diagnostic Imaging | Exercise Therapy

Canada
Concordia University Wisconsin

Completed

Telehealth Powerful Tools for Caregivers Effectiveness Study (TPTC)

Caregivers

United States, Canada
Concert Pharmaceuticals
Celerion

Completed

Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects

Healthy Volunteers

United States
Concordia Laboratories Inc.

Terminated

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Hilar Cholangiocarcinoma

United States, Korea, Republic of, Canada, Switzerland, Germany
Concordia University, Montreal

Terminated

What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder

Obsessive-Compulsive Disorder

Canada
Concordia Pharmaceuticals, Inc

Completed

Study of Salirasib to Treat Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Concordia University, Montreal

Completed

Boosting Performance: The Power of Cranberry Supplementation

Blood Flow | Oxygen Consumption | Mitochondria | Aerobic Capacity

Canada
Concordia University, Montreal

Completed

Effect of a Supervised Exercise Program in Patients With Chronic Low Back Pain

Low Back Pain | Muscle Atrophy | Diagnostic Imaging | Exercise Therapy

Canada
Concordia University, Montreal

Completed

Therapy With an Oxytocin Adjunct for Major Depression (TOAD2015)

Depressive Disorder

Canada

3

Subscribe